Handelsbanken Fonder’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,800
| Closed | -$102K | – | 1597 |
|
|
2024
Q1 | $102K | Hold |
20,800
| – | – | ﹤0.01% | 1547 |
|
|
2023
Q4 | $183K | Buy |
20,800
+7,300
| +54% | +$64.2K | ﹤0.01% | 1516 |
|
|
2023
Q3 | $155K | Hold |
13,500
| – | – | ﹤0.01% | 1509 |
|
|
2023
Q2 | $342K | Buy |
13,500
+2,200
| +19% | +$55.7K | ﹤0.01% | 1279 |
|
|
2023
Q1 | $364K | Hold |
11,300
| – | – | ﹤0.01% | 1181 |
|
|
2022
Q4 | $209K | Buy |
11,300
+1,800
| +19% | +$33.3K | ﹤0.01% | 1419 |
|
|
2022
Q3 | $256K | Buy |
+9,500
| New | +$256K | ﹤0.01% | 1335 |
|
|
2022
Q1 | – | Sell |
-16,100
| Closed | -$263K | – | 1729 |
|
|
2021
Q4 | $263K | Hold |
16,100
| – | – | ﹤0.01% | 1647 |
|
|
2021
Q3 | $449K | Hold |
16,100
| – | – | ﹤0.01% | 1423 |
|
|
2021
Q2 | $477K | Buy |
+16,100
| New | +$477K | ﹤0.01% | 1418 |
|